At NIZO, we accelerate innovation in health and well‑being through advanced microbiome research. Our expertise covers the full development chain — from selecting and characterizing probiotic strains to ensuring their manufacturability at scale. With state‑of‑the‑art facilities and deep experience in intestinal commensals, we help partners unlock the full potential of probiotics for high‑impact products.
NIZO experts Jolanda Lambert, Segment Lead Health & Nutrition, and Ioana Iorga, Strategic Sales Manager, will attend the Microbiome R&D and Business Collaboration Forum, taking place 5–7 May 2026 in The Hague, The Netherlands.
Jolanda will present “Holistic Innovation for Health: De‑Risking Food & Biotics Development from Screening to Scale‑Up” during the Women & Infant Health track on Day 1 at 11:35 AM.
Her session will highlight how successful development of health‑promoting food and biotics ingredients requires an integrated, multi‑step approach — combining AI‑supported high‑throughput screening, in vitro and in vivo benefit verification, and early regulatory and manufacturability assessments. By applying a holistic strategy from the very beginning, companies can significantly increase both technical feasibility and market success. Jolanda will walk through key steps and considerations to demonstrate how end‑to‑end innovation drives better outcomes.
Both experts will be available throughout the conference. If you would like to discuss your project ideas, explore collaboration opportunities, or learn how NIZO can support your development pipeline, you can make an appointment directly with Ioana or Jolanda.